Web portal developed for personalized colorectal cancer risk prediction using genetic and lifestyle factors

Researchers developed a web-based portal called MyGeneRisk Colon for personalized colorectal cancer risk prediction. The tool integrates genetic information with demographic data, family history, and lifestyle factors. The study type, phase, and specific population details were not reported, and the sample size was not provided. The development occurred in a web-based portal setting.

The portal was compared to prediction models based on lifestyle factors alone. The main finding was that prediction accuracy 'improved substantially' when genetic and other factors were incorporated. However, no effect size, absolute numbers, p-values, confidence intervals, or specific performance metrics were reported for this improvement. No primary or secondary outcomes were specified in the available data.

Safety and tolerability data were not reported for this tool development study. No adverse events, serious adverse events, or discontinuations were documented. The study had several limitations including the absence of clinical validation, lack of reported performance metrics, and unspecified study population characteristics. Funding sources and potential conflicts of interest were not disclosed.

This represents a preliminary development of a risk prediction tool without established clinical validation. The reported improvement in accuracy lacks quantitative support and should be interpreted cautiously. Clinical relevance cannot be determined until proper validation studies with reported performance metrics are conducted in defined populations.